3-iodobenzylguanidine has been researched along with Asymptomatic Conditions in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Ghuzlan, A; Baudin, E; Berdelou, A; Bidault, F; Borget, I; Caramella, C; Déandreis, D; Deschamps, F; Dumont, F; Gimenez-Roqueplo, AP; Guillaud Bataille, M; Hartl, D; Leboulleux, S; Lepoutre-Lussey, C; Lumbroso, J; Nascimento, C; Schlumberger, M | 1 |
| Bednarek-Skublewska, A; Chrapko, BE; Głowniak, A; Jaroszyński, AJ; Ksiażek, A; Załuska, W | 1 |
| Beller, GA; Janardhanan, R | 1 |
1 review(s) available for 3-iodobenzylguanidine and Asymptomatic Conditions
| Article | Year |
|---|---|
Radionuclide imaging in stage B heart failure.
Topics: 3-Iodobenzylguanidine; Asymptomatic Diseases; Cardiomyopathies; Chronic Disease; Coronary Artery Disease; Glucose; Heart; Heart Failure; Humans; Myocardial Infarction; Myocardium; Positron-Emission Tomography; Prognosis; Radionuclide Ventriculography; Radiopharmaceuticals; Sarcoidosis; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2012 |
1 trial(s) available for 3-iodobenzylguanidine and Asymptomatic Conditions
| Article | Year |
|---|---|
Iodine-123 metaiodobenzylguanidine myocardial imaging in haemodialysed patients asymptomatic for coronary artery disease: a preliminary report.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Asymptomatic Diseases; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Coronary Artery Disease; Coronary Circulation; Humans; Kidney Failure, Chronic; Middle Aged; Myocardial Perfusion Imaging; Renal Dialysis; Sympathetic Nervous System | 2011 |
1 other study(ies) available for 3-iodobenzylguanidine and Asymptomatic Conditions
| Article | Year |
|---|---|
Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Asymptomatic Diseases; Female; Fluorodeoxyglucose F18; Heterozygote; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Mutation; Pedigree; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Succinate Dehydrogenase; Tomography, X-Ray Computed | 2015 |